Alpine Immune Sciences In... (ALPN)
NASDAQ: ALPN
· Real-Time Price · USD
64.97
0.01 (0.02%)
At close: May 17, 2024, 10:00 PM
Alpine Immune Sciences Revenue
Alpine Immune Sciences reported an annual revenue of $58.88M, reflecting a 95.84% growth. For the quarter ending March 31, 2024, Alpine Immune Sciences generated $7.03M in revenue.
Revenue (ttm)
58.88M
Revenue Growth
95.84%
Price / Sales Ratio
16.19
Revenue / Employee
414.62K
Employees
142
Market Cap
4.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 58.88M | +95.84% |
| Dec 31, 2022 | 30.06M | +28.24% |
| Dec 31, 2021 | 23.44M | +151.13% |
| Dec 31, 2020 | 9.34M | +436.49% |
| Dec 31, 2019 | 1.74M | +146.81% |
| Dec 31, 2018 | 705K | -59.27% |
| Dec 31, 2017 | 1.73M | -41.32% |
| Dec 31, 2016 | 2.95M | +499.59% |
| Dec 31, 2015 | 492K | +Infinity% |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |
| Dec 31, 2012 | 0 | n/a |